Screener
JBT Marel Corporation JBTM Protein Solutions — R&D
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by JBT Marel Corporation in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: JBT Marel Corporation’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053548
| (In millions) | Three Months Ended June 30, 2026 / Protein Solutions | Three Months Ended June 30, 2026 / Prepared Food and Beverage Solutions | Three Months Ended June 30, 2026 / Total | Three Months Ended June 30, 2025 / Protein Solutions | Three Months Ended June 30, 2025 / Prepared Food and Beverage Solutions | Three Months Ended June 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Revenue | $467 | $514 | $421 | $514 | ||
| Less: | ||||||
| Cost of sales | 282 | 340 | 270 | 330 | ||
| Research and development | 11 | 6 | 21 | 10 | ||
| Other segment items (1) | 95 | 107 | 87 | 112 | ||
| Add: | ||||||
| Depreciation and amortization | 33 | 29 | 43 | 32 | ||
| Segment Adjusted EBITDA | $112 | $90 | $202 | $86 | $94 | $180 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is JBT Marel Corporation's protein solutions — R&D?
- JBT Marel Corporation (JBTM) reported protein solutions — R&D of $11M in Q2 2026.
- What does protein solutions — R&D mean?
- Reflects the expenditures incurred by the Protein Solutions segment to develop new technologies, improve existing product lines, and innovate food processing solutions. This investment is critical for maintaining a competitive advantage and driving long-term product differentiation. It indicates the segment's commitment to future growth through technological advancement.
Ask your AI about JBT Marel Corporation's protein solutions — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude